Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2017

Open Access 01-12-2017 | Study protocol

The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer’s disease patients: study protocol for a randomized controlled trial

Authors: Weina Peng, Jing Zhou, Min Xu, Qing Feng, Lulu Bin, Zhishun Liu

Published in: Trials | Issue 1/2017

Login to get access

Abstract

Background

Alzheimer’s disease is a progressive neurodegenerative disease. Although some of the current treatments offer some symptomatic relief, this disease cannot be cured at present. Electroacupuncture may be effective for Alzheimer’s disease for cognitive function, but the evidence for its effectiveness is still limited. The aim of this study is to evaluate the add-on effect of electroacupuncture to donepezil for improving the cognitive function of Alzheimer’s disease.

Methods/design

A total of 334 participants with Alzheimer’s disease will be randomly assigned to either an electroacupuncture combined with donepezil group or a donepezil group with a ratio of 1:1. Participants in the electroacupuncture combined with donepezil group will receive electroacupuncture in addition to donepezil for 12 weeks and will keep taking donepezil for the following 24 weeks. Participants in the control group will take donepezil only. The primary outcome is the change from baseline in the total score of the Alzheimer’s Disease Assessment Scale-cognition at week 12. A follow-up will be conducted 24 weeks after the treatment.

Discussion

We expect to verify the hypothesis that acupuncture in addition to donepezil is better than donepezil in improving the cognitive function of patients with Alzheimer’s disease. This trial has a limitation that participant blinding is impossible.

Trial registration

Clinical Trials.gov: ID: NCT02305836. Registered on 13 November 2014.
Appendix
Available only for authorised users
Literature
1.
Prince M, Brycea R, Albanesea E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63–75.CrossRefPubMed
2.
Zhang ZX, Zahner GE, Roman GC, Liu J, Hong Z, Qu QM, et al. Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol. 2005;62:447–53.CrossRefPubMed
3.
Alzheimer’s Association. 2011 Alzheimer’s disease facts and figures. Alzheimers Dement. 2011;7:208–44.CrossRef
4.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. International global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–7.CrossRefPubMedPubMedCentral
5.
Wimo A, Winblad B, Jonsson L. The worldwide societal costs of dementia: estimate for 2009. Alzheimers Dement. 2010;6:98–103.CrossRefPubMed
6.
Mischoulon D, Raab MF. The role of folate in depression and dementia. Clin Psychiatry. 2007;68(suppl10):28–33.
7.
Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H. Cholinesterase inhibitors for patients with Alzheimer’s disease: systematic review of randomised clinical trials. BMJ. 2005;6:321–7.CrossRef
8.
9.
Atri A, Shaugnessy LW, Locascio JJ, Growdon JH. Long-term course and effectiveness of combination therapy in Alzheimer’s disease. Alzheimer Dis Assoc Disord. 2008;22:209–10.CrossRefPubMedPubMedCentral
10.
Hansen R, Gartlehner G, Webb PA. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. Clin Interv Aging. 2008;3:211–55.PubMedPubMedCentral
11.
12.
Lin CR, Zhang JX, Guo JK, et al. The research of impact of electroacupuncture by using method of “Tiao Shen Yi Zhi” on patients with Alzheimer’s disease. Chin J Gerontol. 2014;34:2225–6.
13.
Zhao LG, Ma L, Li YJ, et al. The clinical research of effect on acupuncturing at GV 20 and GV14 for treating Alzheimer’s disease. JCAM. 2007;23:42–3.
14.
Hu QC, Sun ZY, Meng Y, et al. The effect of acupuncture for treating patients with Alzheimer’s disease by using the method of “Yi Qi Tiao Xue, Fu Ben Pei Yuan”. Shan Xi J Tradit Chin Med. 2001;31:343–4.
15.
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.CrossRefPubMedPubMedCentral
16.
Tian JZ, Shi J, Wei MQ, Wang YY. A Chinese version of clinical criteria for the diagnosis of Alzheimer’s disease. Chin J Front Med Sci. 2012;4:1–6.
17.
Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, et al. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology. 2007;69:459–69.CrossRefPubMed
18.
Tan MJ, Ma Y, Li Q, Zhang LC. Bibliometric analysis of literature on acupuncture and moxibustion in the treatment of Alzheimer’s disease. J Clin Acupunct Moxibustion. 2012;28:46–8.
19.
Huang ZN, Huang Y, Lu YJ, Wu MX, Xiao HL. Research on the regular pattern of selecting acupoints when treating Alzheimer’s disease with acupuncture. Chin J Basic Med Tradit Chin Med. 2010;16:805–7.
20.
Zhou K, Fang J, Wang X, et al. Characterization of de qi with electroacupuncture at acupoints with different properties. J Altern Complement Med. 2011;17:1007–13.CrossRefPubMedPubMedCentral
21.
Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984;141:1356–64.CrossRefPubMed
22.
Zhang Y, Lin C, Zhang L, Cui Y, Gu Y, Guo J, et al. Cognitive improvement during treatment for mild Alzheimer’s disease with a Chinese herbal formula: a randomized controlled trial. PLoS ONE. 10(6):e0130353. doi:10.​1371/​journal.​pone.​0130353.
23.
Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease. Neurology. 2001;57:613–20.CrossRefPubMed
24.
Philip S, Laura VDP. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 2012;83:1038–40.CrossRef
25.
Zec RF, Burkett NR. Non-pharmacological and pharmacological treatment of the cognitive and behavioral symptoms of Alzheimer’s disease. NeuroRehabilitation. 2008;23:425–83.PubMed
26.
Matthews HP, Korbey J, Wilkinson DG, Rowden J. Donepezil in Alzheimer’s disease: eighteen month results from Southampton Memory Clinic. Int J Geriatr Psychiatry. 2000;5:713–20.CrossRef
27.
Yu X, Wang LH, Li SR, Chen YF, Li DH, He J. Discriminatory potential of the Chinese version of ADAS-Cog for mild versus moderate Alzheimer disease. Chin Ment Health J. 2005;19:31–3.
28.
Joseph LS. Multiple imputation: a Primer. Stat Methods Med Res. 1999;8:3–15.CrossRef
29.
Peng J, Luo L, Xu L, Chen X. Therapeutic efficacy observation on electroacupuncture for Alzheimer’s disease. J Acupunct Tuina Sci. 2015;13:171–4.CrossRef
30.
Liu ZB, Niu WM, Yang XH, Niu XM. The clinical research of impact on cognitive function of patients with Alzheimer’s disease by using “Xiu Sanzhen”. Shan Xi J Tradit Chin Med. 2008;29:11–2.
31.
32.
Carrasco MM, Agüera L, Gil P, Moríñigo A, Leon T. Safety and effectiveness of donepezil on behavioral symptoms in patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2011;25:333–40.CrossRefPubMed
33.
Schwam E, Xu Y. Cognition and function in Alzheimer’s disease: identifying the transitions from moderate to severe disease. Dement Geriatr Cogn Disord. 2010;29:309–16.CrossRefPubMed
34.
Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, et al. Clinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014. J Intern Med. 2014;275:251–83.CrossRefPubMedPubMedCentral
35.
Rogers SL, Friedhoff LT. Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: an interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol. 1998;8:67–75.CrossRefPubMed
36.
Wang Y, Qin WG, Yu CD. Clinical observation on effect of cranial suture acupuncture combined with donepezil hydrochloride tablets for Alzheimer’s disease. WJAM. 2014;24:19–24.
37.
Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects. J Clin Epidemiol. 2000;53:786–92.CrossRefPubMed
38.
Bishop FL, Yardley L, Prescott P, Cooper C, Little P, Lewith GT. Psychological covariates of longitudinal changes in back-related disability in patients undergoing acupuncture. Clin J Pain. 2015;31:254–64.CrossRefPubMedPubMedCentral
Metadata
Title
The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer’s disease patients: study protocol for a randomized controlled trial
Authors
Weina Peng
Jing Zhou
Min Xu
Qing Feng
Lulu Bin
Zhishun Liu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-017-2052-y

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue

Methodology

A comparison of approaches for adjudicating outcomes in clinical trials

Study protocol

Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial

Research

Alcohol-free essential oils containing mouthrinse efficacy on three-day supragingival plaque regrowth: a randomized crossover clinical trial

Study protocol

Antibiotic treatment In patients with chronic low back pain and Modic changes (the AIM study): study protocol for a randomised controlled trial

Study protocol

Effectiveness, costs and cost-effectiveness of chiropractic care and physiotherapy compared with information and advice in the treatment of non-specific chronic low back pain: study protocol for a randomised controlled trial

Research

The pathway to RCTs: how many roads are there? Examining the homogeneity of RCT justification